Melanoma-associated antigen B16 (MAGEB16)

Melanoma-associated antigen B16 (MAGEB16) is a member of the MAGE family, which is broadly implicated in transcriptional control and is most commonly expressed in cancer and testicular tissues[2][1][6]. MAGEB16 encodes a protein predicted to negatively regulate transcription by RNA polymerase II and to be active in the nucleus, but it is not directly linked to enzymatic activity, receptor signaling, or drug targeting at this time[2][6]. While other MAGE family proteins have demonstrated roles in ubiquitination, transcription factor interaction, and oncogenic processes such as cell proliferation and immune evasion[1], MAGEB16 itself lacks functional annotation and experimental literature, and is sometimes listed as a pseudogene[2]. Diseases associated with MAGEB16 include melanoma, consistent with the cancer/testis antigen profile of its gene family[2]. Due to the lack of evidence for direct drug interactions, mechanisms of action, or safety considerations, MAGEB16 is not considered a validated drug target nor a clinical biomarker based on current database and literature search[2][6].

Other names

MAGEB16Melanoma-associated antigen B16MAGE-B16 antigenmelanoma antigen family B, 16 (pseudogene)